355 related articles for article (PubMed ID: 19126644)
1. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
[TBL] [Abstract][Full Text] [Related]
2. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
3. A direct role of transcription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL60 cells.
Ishida S; Shudo K; Takada S; Koike K
Cell Growth Differ; 1995 Mar; 6(3):229-37. PubMed ID: 7794791
[TBL] [Abstract][Full Text] [Related]
4. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
Araki K; Nakajima Y; Eto K; Ikeda MA
Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
[TBL] [Abstract][Full Text] [Related]
5. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product.
Luo Q; Li J; Cenkci B; Kretzner L
Oncogene; 2004 Feb; 23(5):1088-97. PubMed ID: 14716294
[TBL] [Abstract][Full Text] [Related]
6. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
Polzin RG; Benlhabib H; Trepel J; Herrera JE
Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
[TBL] [Abstract][Full Text] [Related]
7. Three distinct elements within the murine c-myc promoter are required for transcription.
Moberg KH; Logan TJ; Tyndall WA; Hall DJ
Oncogene; 1992 Mar; 7(3):411-21. PubMed ID: 1549358
[TBL] [Abstract][Full Text] [Related]
8. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription.
Cartwright P; Müller H; Wagener C; Holm K; Helin K
Oncogene; 1998 Aug; 17(5):611-23. PubMed ID: 9704927
[TBL] [Abstract][Full Text] [Related]
9. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
10. Identification of a set of protein species approximately 40 kDa as high-affinity DNA binding factor(s) to the cell cycle regulatory region of the human thymidine kinase promoter.
Kim EC; Rawlings SL; Li LJ; Roy B; Lee AS
Cell Growth Differ; 1996 Dec; 7(12):1741-9. PubMed ID: 8959343
[TBL] [Abstract][Full Text] [Related]
11. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.
Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K
Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional repression and activation in the same cell type of the human c-MYC promoter by the retinoblastoma gene protein: antagonisation of both effects by SV40 T antigen.
Batsché E; Lipp M; Cremisi C
Oncogene; 1994 Aug; 9(8):2235-43. PubMed ID: 8036009
[TBL] [Abstract][Full Text] [Related]
13. Transfer of E2F-1 to human glioma cells results in transcriptional up-regulation of Bcl-2.
Gomez-Manzano C; Mitlianga P; Fueyo J; Lee HY; Hu M; Spurgers KB; Glass TL; Koul D; Liu TJ; McDonnell TJ; Yung WK
Cancer Res; 2001 Sep; 61(18):6693-7. PubMed ID: 11559537
[TBL] [Abstract][Full Text] [Related]
14. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately.
Batsché E; Crémisi C
Oncogene; 1999 Oct; 18(41):5662-71. PubMed ID: 10523846
[TBL] [Abstract][Full Text] [Related]
15. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
[TBL] [Abstract][Full Text] [Related]
16. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation.
Yamada M; Kondo T; Ashizawa S; Takebayashi T; Higashi H; Hatakeyama M
Cytokine; 2002 Jan; 17(2):91-7. PubMed ID: 11886176
[TBL] [Abstract][Full Text] [Related]
17. Different regulation of c-Myc- and E2F-1-induced apoptosis during the ongoing cell cycle.
Hengstschläger M; Hölzl G; Hengstschläger-Ottnad E
Oncogene; 1999 Jan; 18(3):843-8. PubMed ID: 9989838
[TBL] [Abstract][Full Text] [Related]
18. The periodic down regulation of Cyclin E gene expression from exit of mitosis to end of G(1) is controlled by a deacetylase- and E2F-associated bipartite repressor element.
Polanowska J; Fabbrizio E; Le Cam L; Trouche D; Emiliani S; Herrera R; Sardet C
Oncogene; 2001 Jul; 20(31):4115-27. PubMed ID: 11464278
[TBL] [Abstract][Full Text] [Related]
19. MAZ induces MYB expression during the exit from quiescence via the E2F site in the MYB promoter.
Álvaro-Blanco J; Urso K; Chiodo Y; Martín-Cortázar C; Kourani O; Arco PG; Rodríguez-Martínez M; Calonge E; Alcamí J; Redondo JM; Iglesias T; Campanero MR
Nucleic Acids Res; 2017 Sep; 45(17):9960-9975. PubMed ID: 28973440
[TBL] [Abstract][Full Text] [Related]
20. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast.
Ben-Yosef T; Yanuka O; Benvenisty N
Oncogene; 1996 Nov; 13(9):1859-66. PubMed ID: 8934531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]